In this article, Gregory Vistnes outlines why Antitrust Agencies care about clinical integration, an issue that might seem primarily an issue of concern to the healthcare community and not antitrust enforcers, and how the agencies typically evaluate the competitive significance of clinical integration.
CRA strengthens its Antitrust & Competition Economics Practice
“We are pleased to welcome Nate to CRA’s Antitrust & Competition Economics Practice,” said Paul Maleh, President and Chief Executive Officer of Charles River...